UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 14, 2021 5:00 P.M.
Form:
S-3
CIK:
0001764013
Company Name:
Immunovant, Inc.
File Number:
333-251865